L-arginine
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Brand Names
- Aminosyn II 7 %, Sulfite-free, Clinimix 2.75/5, Clinimix E 2.75/5, Olimel
- Generic Name
- L-arginine
- DrugBank Accession Number
- DB17289
- Background
Not Available
- Type
- Small Molecule
- Groups
- Approved, Nutraceutical
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Product Ingredients
Ingredient UNII CAS InChI Key L-arginine hydrochloride Not Available 32042-43-6 Not applicable - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Aminosyn L-arginine (980 mg / 100 mL) + Alanine (1280 mg / 100 mL) + Glycine (1280 mg / 100 mL) + Histidine (300 mg / 100 mL) + Isoleucine (720 mg / 100 mL) + Leucine (940 mg / 100 mL) + Lysine acetate (720 mg / 100 mL) + Methionine (400 mg / 100 mL) + Phenylalanine (440 mg / 100 mL) + Proline (860 mg / 100 mL) + Serine (420 mg / 100 mL) + Threonine (520 mg / 100 mL) + Tryptophan (160 mg / 100 mL) + Tyrosine (44 mg / 100 mL) + Valine (800 mg / 100 mL) Solution Intravenous Icu Medical Canada Inc 1979-12-31 2019-01-24 Canada Aminosyn II L-arginine (1018 mg / 100 mL) + Alanine (993 mg / 100 mL) + Aspartic acid (700 mg / 100 mL) + Glutamic acid (738 mg / 100 mL) + Glycine (500 mg / 100 mL) + Histidine (300 mg / 100 mL) + Isoleucine (660 mg / 100 mL) + Leucine (1000 mg / 100 mL) + Lysine acetate (1050 mg / 100 mL) + Methionine (172 mg / 100 mL) + N-acetyltyrosine (270 mg / 100 mL) + Phenylalanine (298 mg / 100 mL) + Proline (722 mg / 100 mL) + Serine (530 mg / 100 mL) + Threonine (400 mg / 100 mL) + Tryptophan (200 mg / 100 mL) + Valine (500 mg / 100 mL) Solution Intravenous Icu Medical Canada Inc 1987-12-31 Not applicable Canada Aminosyn II L-arginine (1527 mg / 100 mL) + Alanine (1490 mg / 100 mL) + Aspartic acid (1050 mg / 100 mL) + Glutamic acid (1107 mg / 100 mL) + Glycine (750 mg / 100 mL) + Histidine (450 mg / 100 mL) + Isoleucine (990 mg / 100 mL) + Leucine (1500 mg / 100 mL) + Lysine acetate (1575 mg / 100 mL) + Methionine (258 mg / 100 mL) + N-acetyltyrosine (405 mg / 100 mL) + Phenylalanine (447 mg / 100 mL) + Proline (1083 mg / 100 mL) + Serine (795 mg / 100 mL) + Threonine (600 mg / 100 mL) + Tryptophan (300 mg / 100 mL) + Valine (750 mg / 100 mL) Solution Intravenous Icu Medical Canada Inc 1995-12-31 Not applicable Canada AMINOVEN SOLUTION FOR INFUSION 15% L-arginine (20 g/L) + Alanine (25 g/L) + Glycine (18.5 g/L) + Histidine (7.3 g/L) + Isoleucine (5.2 g/L) + Leucine (8.9 g/L) + Lysine acetate (11.1 g/L) + Methionine (3.8 g/L) + Phenylalanine (5.5 g/L) + Proline (17 g/L) + Serine (9.6 g/L) + Taurine (2 g/L) + Threonine (8.6 g/L) + Tryptophan (1.6 g/L) + Tyrosine (0.4 g/L) + Valine (5.5 g/L) Solution Intravenous FRESENIUS KABI (SINGAPORE) PTE LTD 2021-09-30 Not applicable Singapore Clinimix L-arginine (690 mg / 100 mL) + Alanine (1242 mg / 100 mL) + Dextrose, unspecified form (5 g / 100 mL) + Glycine (618 mg / 100 mL) + Histidine (288 mg / 100 mL) + Isoleucine (360 mg / 100 mL) + Leucine (438 mg / 100 mL) + Lysine hydrochloride (348 mg / 100 mL) + Methionine (240 mg / 100 mL) + Phenylalanine (336 mg / 100 mL) + Proline (408 mg / 100 mL) + Serine (300 mg / 100 mL) + Threonine (252 mg / 100 mL) + Tryptophan (108 mg / 100 mL) + Tyrosine (24 mg / 100 mL) + Valine (348 mg / 100 mL) Solution Intravenous Baxter Laboratories Not applicable Not applicable Canada
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- 74-79-3
- InChI Key
- Not Available
- InChI
- Not Available
- IUPAC Name
- Not Available
- SMILES
- Not Available
References
- General References
- Not Available
- External Links
- Wikipedia
- Arginine
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 2 Active Not Recruiting Treatment Carcinoid Tumors / Medulloblastomas / Neuroblastoma (NB) / Neuroendocrine Tumors 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Solution Intravenous 18.5 g/L Solution Intravenous Solution Intravenous 25 g/L Emulsion Intravenous - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
- Not Available
- Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at December 01, 2022 22:27 / Updated at December 13, 2022 10:46